drugset / Trial / NCT00437489
A Clinical Trial Comparing The Efficacy And Safety Of 2 Different Initial Dose Prescriptions For Exubera.
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary objective of this study is to assess whether a simple initial dose prescription of inhaled insulin (Exubera) achieves glycemic control (HbA1c) after 16 weeks that is non-inferior compared to the standard weight-based formula.
Timeline
- Start
- 2007-06
- Primary completion
- 2007-12
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin | Protein / enzyme biologic | 0.05 mg/kg | Inhaled |
| Subject | Insulin | Protein / enzyme biologic | 1 mg | Inhaled |